Earnings Season is always quite busy especially as I write for a huge dividend website so I am a little quieter than normal
saying that, I still had time to add some $VTRS to my portfolio. More risky than i'm used to but they have a great pipeline and seem a little on the value side compared to industry peers.
Also a good choice for those of us who are invested in companies such as $ABBV where biosimilars will have a huge impact
No comments yetBe the first to add your insight!